表紙
市場調查報告書

搭配診斷(CDx)的全球市場 2019年∼2023年

Global Companion Diagnostics Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 298805
出版日期 內容資訊 英文 118 Pages
訂單完成後即時交付
價格
Back to Top
搭配診斷(CDx)的全球市場 2019年∼2023年 Global Companion Diagnostics Market 2019-2023
出版日期: 2018年12月31日內容資訊: 英文 118 Pages
簡介

搭配診斷(CDx),因為其特異性,沒有像市場上可取得的其他檢測套組等一樣地廣泛流通。因此,必須重點性致力於流通網路的改善與提高終端用戶的取得性。搭配診斷(CDx)的全球市場預測直至2023年,將以25%的年複合成長率發展。

本報告提供全球搭配診斷(CDx)市場調查,市場概要,各終端用戶、各地區的市場規模的變化與預測,市場成長要素及課題分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 報告範圍

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模的預測

第5章 波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 市場比較:各終端用戶
  • 生命科學
  • 健康中心
  • 其他
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 市場區隔:各地區

  • 市場區隔:各地區
  • 市場區隔:各地區
  • 歐洲、中東、非洲
  • 亞太地區
  • 主要國家
  • 市場機會

第9章 成長要素與課題

  • 市場成長要素
  • 市場課題

第10章 市場趨勢

第11章 業者情勢

  • 概要
  • 創造性破壞狀況

第12章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • QIAGEN
  • Thermo Fisher Scientific

第13章 附錄

  • 調查方法
  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR30609

About this market:

The growing importance for promotional activities to drive market growth. The companion diagnostics are not as frequently marketed like other test kits and devices that are available in the market due to its specificity, wherein it can be used only for a drug. Therefore, more emphasis must be provided toward improving distribution network and increasing the product availability to end-users. Online media and search engines are the primary sources for advertising, owing to the low return on investment and limited visibility of other media. Technavio's analysts have predicted that the companion diagnostics market will register a CAGR of almost 25% by 2023.

Market Overview:

Rising use of personalized medicine

Personalized medicine is a multi-faceted method to patient care that not only improves capacity to diagnose and treat diseases but offers the potential to distinguish diseases at an earlier stage, which makes it easier for practitioners to treat effectively. With its specificity in treating particular disease based on individual's genetic characteristics, personalized medicine is gaining popularity.

Lack of manpower

Companion diagnostic tests are highly technical, and care must be taken at each step to facilitate a successful execution of these tests, to generate reproducible results. A major challenge in these scientific fields is the lack of technically skilled and trained staff.

For the detailed list of factors that will drive and challenge the growth of the companion diagnostics market during the 2019-2023, view our report.

Competitive Landscape:

The market appears to be fragmented and with the presence of several companies including Abbott and Agilent Technologies the competitive environment is quite intense. Factors such as the rising use of personalized medicine and the growing importance for promotional activities, will provide considerable growth opportunities to companion diagnostics manufactures. Abbott, Agilent Technologies, F. Hoffmann-La Roche, QIAGEN, and Thermo Fisher Scientific are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1. Preface
  • 2.2. Preface
  • 2.3. Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Life science - Market size and forecast 2018-2023
  • Health centers - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • QIAGEN
  • Thermo Fisher Scientific

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Years in consideration
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Life science - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Life science - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Health centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Health centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Decision framework
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott - Vendor overview
  • Exhibit 46: Abbott - Business segments
  • Exhibit 47: Abbott - Organizational developments
  • Exhibit 48: Abbott - Geographic focus
  • Exhibit 49: Abbott - Segment focus
  • Exhibit 50: Abbott - Key offerings
  • Exhibit 51: Agilent Technologies - Vendor overview
  • Exhibit 52: Agilent Technologies - Business segments
  • Exhibit 53: Agilent Technologies - Organizational developments
  • Exhibit 54: Agilent Technologies - Geographic focus
  • Exhibit 55: Agilent Technologies - Segment focus
  • Exhibit 56: Agilent Technologies - Key offerings
  • Exhibit 57: F. Hoffmann-La Roche - Vendor overview
  • Exhibit 58: F. Hoffmann-La Roche - Business segments
  • Exhibit 59: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 60: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 61: F. Hoffmann-La Roche - Segment focus
  • Exhibit 62: F. Hoffmann-La Roche - Key offerings
  • Exhibit 63: QIAGEN - Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: List of abbreviations
Back to Top